NuVasive sheds $60M patent liability in appeals court decision; India develops medical device draft guidance;

 @FierceMedDev: J&J has settled the first three lawsuits involving failure of its ASR hip implants. Thousands more to come. Release | Follow @FierceMedDev

 @MarkHFierce: bioMerieux got slapped with an FDA warning letter for quality violations regarding a NC Dx manufacturing facility. Warning Letter | Follow @MarkHFierce

 @DamianFierce: Berkeley's Ekso Bionics is looking to expand the use of its robotic walking aid. Report | Follow @DamianFierce

> Illumina ($ILMN) is partnering with Partners HealthCare in Boston to combine sequencing and software technology. Story

> General Dynamics ($GD) gets nearly $42 million to provide support programs for medical device, drug and vaccine development programs for the U.S. Army. Release

> NuVasive no longer has to pay $60 million NeuroVision Medical Products, as an appeals court reversed the outcome of a lower court patent verdict that was favor of rival NeuroVision. A retrial is likely, MassDevice reports. Story

> India's health ministry is planning to issue a draft guidance on the labeling, manufacturing and shelf life of medical devices, seeking industry feedback before implementing new rules. Story

> GenMark Diagnostics ($GNMK) got 510(k) clearance for its eSensor respiratory virus panel test, designed to detect 14 clinically relevant viruses from patients with influenza-like illness. More

> Medtronic ($MDT) may be on the mend with a turnaround underway but its shares are still "cheap," Barron's reports. Story

> The United Kingdom will host its first conference and exhibition devoted solely to the growing medical device manufacturing industry. Story

Biotech News

 @FierceBiotech: D-Day for Sanofi multiples cerlosis drug Aubagio as deep R&D cuts loom. Story | Follow @FierceBiotech

 @JohnCFierce: Lundbeck, Otsuka scramble to get antipsychotic back on FDA track--(competing with Alkermes). Article | Follow @JohnCFierce

 @RyanMFierce: My take on Illumina's alliance with Partners HealthCare to combine sequencing and software. Story | Follow @RyanMFierce

> UNC biotech spinoff grabs J&J deal and $16M A round for diabetic nephropathy drug. Story

> GlaxoSmithKline anti-smoking drug combats addictive cravings. Report

> Sanofi's dengue fever vaccine trial flop rattles the experts. News

Pharma News

 @FiercePharma: Sanofi workers to strike as day of reckoning nears. More | Follow @FiercePharma

> Merck's Singulair sales free-fall 90% in 4 weeks. Article

> Roche loses patent fight in India as Novartis fights on. Report

> Pfizer's Prevenar 13 gets a shot in the arm with WHO approval. Story

Biomarkers News

> Janssen's Remicade attacks inflammation to beat depression. Article

> Increased antibody levels tag raised rheumatoid arthritis risk. Story

> Researchers develop genetic test to fine-tune warfarin dose. Item

> Breast cancer protein pinpoints survival chances. More

Drug Delivery News

> Hopkins cracks blood-brain barrier with nanobeads. More

> Sublingual opioid addiction therapy moves closer to market. Report

> Silence breaks out with preclinical data on Atu111. Story

> InSite eyes next-generation DuraSite delivery. Article

> Anti-HIV vaginal ring shows hints of efficacy. More

> AZ goes Down Under for cancer conjugate deal. Item

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.